Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 17/20 | 0.59 |
| ▸ | NPY1R | P25929 | 10/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.59 |
| ▸ | NPY2R | P49146 | 6/20 | 0.59 |
| ▸ | CD40 | P25942 | 2/20 | 0.56 |
| ▸ | TFPI | P10646 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29376109 | 1.00 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL30516186 | 0.95 | TFPI (0.55) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL30153268 | 0.94 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31232432 | 0.92 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL30939697 | 0.92 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL5965085 | 0.92 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL5965061 | 0.92 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL30939704 | 0.92 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL31256982 | 0.92 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RCD40 | |
| SCHEMBL30516190 | 0.91 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RCD40 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851468-B2 | Treatment of neurological diseases | UNIVERSITY OF LANCASTER (GB) | 2023-12-26 | — | — | US | disclosed |
| CN-110312520-B | Treatment of neurological disorders | 兰卡斯特大学企业有限公司 | 2023-01-24 | — | — | CN | disclosed |
| US-20220033457-A1 | TREATMENT OF NEUROLOGICAL DISEASES | UNIVERSITY OF LANCASTER (GB) | 2022-02-03 | — | — | US | disclosed |